Safety and efficacy of edaravone in patients with amyotrophic lateral sclerosis: a systematic review and meta-analysis
2023; Springer Science+Business Media; Volume: 44; Issue: 10 Linguagem: Inglês
10.1007/s10072-023-06869-8
ISSN1590-3478
AutoresAnas Zakarya Nourelden, Ibrahim Kamal, Abdulrahman Ibrahim Hagrass, Abdelrahman Tawfik, Mahmoud M. Elhady, Ahmed Hashem Fathallah, Mona Muhe Eldeen Eshag, Mohamed Sayed Zaazouee,
Tópico(s)Neurogenetic and Muscular Disorders Research
ResumoThe study aims to increase understanding of edaravone's efficacy and safety as an amyotrophic lateral sclerosis (ALS) treatment and provide significant insights regarding this field's future research.
Referência(s)